The fibrillogenic L178H variant of apolipoprotein A-I forms helical fibrils

A number of amyloidogenic variants of apoA-I have been discovered but most have not been analyzed. Previously, we showed that the G26R mutation of apoA-I leads to increased β-strand structure, increased N-terminal protease susceptibility, and increased fibril formation after several days of incubati...

Full description

Bibliographic Details
Main Authors: Jitka Petrlova, Trang Duong, Megan C. Cochran, Annika Axelsson, Matthias Mörgelin, Linda M. Roberts, Jens O. Lagerstedt
Format: Article
Language:English
Published: Elsevier 2012-03-01
Series:Journal of Lipid Research
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0022227520413549
id doaj-34ec895221cc42f0a984351acafe00e3
record_format Article
spelling doaj-34ec895221cc42f0a984351acafe00e32021-04-28T06:04:37ZengElsevierJournal of Lipid Research0022-22752012-03-01533390398The fibrillogenic L178H variant of apolipoprotein A-I forms helical fibrilsJitka Petrlova0Trang Duong1Megan C. Cochran2Annika Axelsson3Matthias Mörgelin4Linda M. Roberts5Jens O. Lagerstedt6Department of Experimental Medical Sciences, Lund University, S-221 84 Lund, Sweden; andDepartment of Chemistry, California State University Sacramento, Sacramento, CA 95819Department of Chemistry, California State University Sacramento, Sacramento, CA 95819Department of Experimental Medical Sciences, Lund University, S-221 84 Lund, Sweden; andDepartment of Experimental Medical Sciences, and Department of Infection Medicine, Lund University, S-221 84 Lund, Sweden; andTo whom correspondence should be addressed. (J. O. L.) or (L. M. R.); Department of Chemistry, California State University Sacramento, Sacramento, CA 95819To whom correspondence should be addressed. (J. O. L.) or (L. M. R.); Department of Experimental Medical Sciences, Lund University, S-221 84 Lund, Sweden; andA number of amyloidogenic variants of apoA-I have been discovered but most have not been analyzed. Previously, we showed that the G26R mutation of apoA-I leads to increased β-strand structure, increased N-terminal protease susceptibility, and increased fibril formation after several days of incubation. In vivo, this and other variants mutated in the N-terminal domain (residues 26 to ∼90) lead to renal and hepatic accumulation. In contrast, several mutations identified within residues 170 to 178 lead to cardiac, laryngeal, and cutaneous protein deposition. Here, we describe the structural changes in the fibrillogenic variant L178H. Like G26R, the initial structure of the protein exhibits altered tertiary conformation relative to wild-type protein along with decreased stability and an altered lipid binding profile. However, in contrast to G26R, L178H undergoes an increase in helical structure upon incubation at 37°C with a half time (t1/2) of about 12 days. Upon prolonged incubation, the L178H mutant forms fibrils of a diameter of 10 nm that ranges in length from 30 to 120 nm. These results show that apoA-I, known for its dynamic properties, has the ability to form multiple fibrillar conformations, which may play a role in the tissue-specific deposition of the individual variants.http://www.sciencedirect.com/science/article/pii/S0022227520413549high density lipoproteinapoA-Ifibril formationamyloidprotein stability
collection DOAJ
language English
format Article
sources DOAJ
author Jitka Petrlova
Trang Duong
Megan C. Cochran
Annika Axelsson
Matthias Mörgelin
Linda M. Roberts
Jens O. Lagerstedt
spellingShingle Jitka Petrlova
Trang Duong
Megan C. Cochran
Annika Axelsson
Matthias Mörgelin
Linda M. Roberts
Jens O. Lagerstedt
The fibrillogenic L178H variant of apolipoprotein A-I forms helical fibrils
Journal of Lipid Research
high density lipoprotein
apoA-I
fibril formation
amyloid
protein stability
author_facet Jitka Petrlova
Trang Duong
Megan C. Cochran
Annika Axelsson
Matthias Mörgelin
Linda M. Roberts
Jens O. Lagerstedt
author_sort Jitka Petrlova
title The fibrillogenic L178H variant of apolipoprotein A-I forms helical fibrils
title_short The fibrillogenic L178H variant of apolipoprotein A-I forms helical fibrils
title_full The fibrillogenic L178H variant of apolipoprotein A-I forms helical fibrils
title_fullStr The fibrillogenic L178H variant of apolipoprotein A-I forms helical fibrils
title_full_unstemmed The fibrillogenic L178H variant of apolipoprotein A-I forms helical fibrils
title_sort fibrillogenic l178h variant of apolipoprotein a-i forms helical fibrils
publisher Elsevier
series Journal of Lipid Research
issn 0022-2275
publishDate 2012-03-01
description A number of amyloidogenic variants of apoA-I have been discovered but most have not been analyzed. Previously, we showed that the G26R mutation of apoA-I leads to increased β-strand structure, increased N-terminal protease susceptibility, and increased fibril formation after several days of incubation. In vivo, this and other variants mutated in the N-terminal domain (residues 26 to ∼90) lead to renal and hepatic accumulation. In contrast, several mutations identified within residues 170 to 178 lead to cardiac, laryngeal, and cutaneous protein deposition. Here, we describe the structural changes in the fibrillogenic variant L178H. Like G26R, the initial structure of the protein exhibits altered tertiary conformation relative to wild-type protein along with decreased stability and an altered lipid binding profile. However, in contrast to G26R, L178H undergoes an increase in helical structure upon incubation at 37°C with a half time (t1/2) of about 12 days. Upon prolonged incubation, the L178H mutant forms fibrils of a diameter of 10 nm that ranges in length from 30 to 120 nm. These results show that apoA-I, known for its dynamic properties, has the ability to form multiple fibrillar conformations, which may play a role in the tissue-specific deposition of the individual variants.
topic high density lipoprotein
apoA-I
fibril formation
amyloid
protein stability
url http://www.sciencedirect.com/science/article/pii/S0022227520413549
work_keys_str_mv AT jitkapetrlova thefibrillogenicl178hvariantofapolipoproteinaiformshelicalfibrils
AT trangduong thefibrillogenicl178hvariantofapolipoproteinaiformshelicalfibrils
AT meganccochran thefibrillogenicl178hvariantofapolipoproteinaiformshelicalfibrils
AT annikaaxelsson thefibrillogenicl178hvariantofapolipoproteinaiformshelicalfibrils
AT matthiasmorgelin thefibrillogenicl178hvariantofapolipoproteinaiformshelicalfibrils
AT lindamroberts thefibrillogenicl178hvariantofapolipoproteinaiformshelicalfibrils
AT jensolagerstedt thefibrillogenicl178hvariantofapolipoproteinaiformshelicalfibrils
AT jitkapetrlova fibrillogenicl178hvariantofapolipoproteinaiformshelicalfibrils
AT trangduong fibrillogenicl178hvariantofapolipoproteinaiformshelicalfibrils
AT meganccochran fibrillogenicl178hvariantofapolipoproteinaiformshelicalfibrils
AT annikaaxelsson fibrillogenicl178hvariantofapolipoproteinaiformshelicalfibrils
AT matthiasmorgelin fibrillogenicl178hvariantofapolipoproteinaiformshelicalfibrils
AT lindamroberts fibrillogenicl178hvariantofapolipoproteinaiformshelicalfibrils
AT jensolagerstedt fibrillogenicl178hvariantofapolipoproteinaiformshelicalfibrils
_version_ 1721504254916558848